相关实验视频
Updated: Jun 16, 2025

07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
254
抑制ADRB2通过调节瘤SOX10-PD-L1轴和T细胞功能来抑制癌症免疫逃避
Yu Zhang1,2,3, Feng Yu1,3, Jing Ouyang1,3
1Department of Clinical Pharmacology, Xiangya Hospital Central South University, Changsha, Hunan, China.
Journal for immunotherapy of cancer
|June 13, 2025
概括
慢性压力通过ADRB2促进癌症,ADRB2通过ADRB2调节SOX10以增加PD-L1. 抑制ADRB2或SOX10可能会提高癌症免疫治疗的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 慢性压力通过通过β2-上腺素受体 (ADRB2) 影响免疫反应,加剧癌症的进展.
- 针对ADRB2的β-抑制剂在增强免疫检查点抑制剂 (ICI) 疗效方面表现有希望,但机制需要澄清.
研究的目的:
- 阐明ADRB2在调节瘤编程死亡连接体1 (PD-L1) 表达和癌症T细胞功能的作用.
- 研究将ADRB2信号与PD-L1调节联系起来的分子途径.
主要方法:
- 在黑色素瘤和结直肠癌 (CRC) 模型中的体内和体外研究.
- RNA测序, luciferase 记者测定,染色体免疫沉-PCR,以及基因淘汰/过度表达实验.
- 通过蛋白激酶A (PKA) 分析ADRB2信号传递及其下游目标SOX10.
主要成果:
- 在黑色素瘤模型中,ADRB2抑制降低了PD-L1,增加了T细胞透,并促进了抗瘤免疫力.
- ADRB2信号调节SOX10,这是一个直接调节PD-L1表达的转录因子.
- 在黑色素瘤和CRC模型中,ADRB2-SOX10-PD-L1轴保持不变,高ADRB2与黑色素瘤患者更好的ICI反应相关.
结论:
- ADRB2和SOX10是免疫抑制瘤微环境的关键调节者.
- 针对ADRB2-SOX10-PD-L1通路提供了一个潜在的战略,以提高ICI的疗效.
- 这些发现强调了在癌症治疗中减轻压力诱导的免疫抑制的治疗目标.
相关概念视频
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K

